Performance of breast MRI for high-risk screening during lactation.

Autor: Nissan N; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Gluskin J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Ochoa-Albiztegui RE; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Fruchtman-Brot H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Sung JS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Jochelson MS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. maxine.jochelson@radnet.com.
Jazyk: angličtina
Zdroj: European radiology [Eur Radiol] 2024 Oct 31. Date of Electronic Publication: 2024 Oct 31.
DOI: 10.1007/s00330-024-11091-x
Abstrakt: Objectives: To assess the diagnostic performance of breast MRI during lactation in the setting of high-risk breast cancer screening.
Materials and Methods: Screening breast MRIs performed between April 2008 and March 2024 were retrospectively reviewed. Background parenchymal enhancement (BPE) grade was compared between lactating patients and patients who recently stopped lactating using the Mann-Whitney test. Breast Imaging Reporting and Data System (BI-RADS) scores prevalence rates were compared between lactating patients and controls encompassing young non-lactating patients using the Chi-square test. Diagnostic performance was calculated for patients with a biopsy reference or a 1-year radiologic follow-up.
Results: One-hundred forty-two screening breast MRIs were performed in lactating patients (n = 104, median age, 36.0 ± 6.0 years). Marked BPE appeared in 82% of cases (116/142), with a higher BPE grade in exams performed during lactation as compared with those performed in patients who had recently ceased lactating (p < 0.001). Screening MRIs performed during lactation had a higher rate of BI-RADS 3 scores (40/142, 28% vs. 683/8922, 7%, p < 0.001) and a lower rate of BI-RADS 1/2 scores (88/142, 62% vs. 7549/8922, 84.6%, p = 0.002) compared with those performed in controls (n = 8922). One pregnancy-associated breast cancer was detected, and one interval-cancer occurred. All MRI-guided biopsies were negative (n = 13). Screening breast MRI during lactation had 50% sensitivity (1/2), 60% specificity (72/120), 2.0% positive predictive value (1/49), and 98.6% negative predictive value (71/82).
Conclusion: The efficacy of breast MRI for high-risk screening during lactation is limited by prominent BPE, leading to an increased rate of BI-RADS 3 categorization and diminished overall specificity.
Key Points: Question Studies on breast MRI during lactation were solely focused on studies conducted in patients with known cancer but not in the screening setting. Findings Screening breast MRI during lactation usually results in marked background parenchymal enhancement, negatively impacting its diagnostic performance. Clinical relevance Despite the lower performance, and amidst the significant risk of pregnancy-associated breast cancer, this screening approach remains relevant for lactating patients with high-risk profiles, such as BReast Cancer (BRCA) carriers. Radiologists should be familiar with the normal appearance of breast MRI during lactation.
(© 2024. The Author(s), under exclusive licence to European Society of Radiology.)
Databáze: MEDLINE
Externí odkaz: